Search
Search
Close this search box.

Daily Cannabis Use Surpasses Alcohol for the First Time, Survey Finds

Daily cannabis use in the US has now outpaced that of alcohol for the first time, according to new national survey data

While alcohol remains more widely used throughout the country, the percentage of cannabis users consuming it on a daily basis overtook those consuming alcohol daily in 2022 for the first time in over four decades.

According to the research, which was based on data from the National Survey on Drug Use and Health, cannabis use has seen a substantial increase since 2008, with past-year usage rising by 120% and the total days of use reported per capita jumping by 218%.

Notably, from 1992 to 2022, daily or near daily (DND) cannabis use increased 15-fold, from 0.9 million to 17.7 million users. This increase far outpaced alcohol consumption trends.

In 1992, DND alcohol users vastly outnumbered DND cannabis users (8.9 million vs. 0.9 million). By 2022, the number of DND cannabis users would surpass that of DND alcohol users (17.7 million vs. 14.7 million).

Cannabis use patterns have, according to the research, evolved to resemble cigarette consumption more closely than alcohol.

Additionally, marijuana is no longer predominantly a young person’s drug. In 2022, individuals aged 35 and older accounted for more days of use than those under 35.

Jonathan Caulkins, cannabis policy researcher at Carnegie Mellon University, said: “A good 40% of current cannabis users are using it daily or near daily, a pattern that is more associated with tobacco use than typical alcohol use.”

🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?